Molecular Laboratory
The state-of-the-art Molecular Laboratory at Bellevue Medical Center specializes in diagnosing infectious diseases, oncological, and genetic diseases.
Equipped with modern and automated instruments, the Molecular Laboratory provides DNA/RNA-based molecular tests with highly accurate results that are obtained in an exceptional turnaround time.
To ensure accuracy and precision, the Molecular Laboratory uses internationally approved reagents and best-in-class instrumentation.
The laboratory has a team of experts in molecular diagnostics who have years of experience, including laboratory technologists, molecular biologists, medical technologists, physicians and other healthcare professionals. They are committed to providing accurate and reliable results to aid in the diagnosis and treatment of patients. Their in-depth knowledge and experience in molecular diagnostics allow them to perform complex tests and interpret results with a high degree of accuracy.
With its timely and accurate results, the Molecular Laboratory helps accelerate treatment decisions.
Molecular Microbiology:
| Targets | Results available within | |
| Human Immunodeficiency Virus (HIV) – Quantitative | HIV-1 RNA | 3 working days |
| Hepatitis B Virus (HBV) – Quantitative | HBV DNA | 3 working days |
| Hepatitis C Virus (HCV) – Quantitative | HCV Genotypes 1-6 | 3 working days |
| SARS-CoV-2*:
|
RDRP, N and E genes of SARS-CoV-2 | Same Day Results |
| Mycobacterium tuberculosis Complex | M. tuberculosis, M. africanum, M. bovis, M. microti, M. canettii, M. pinnipedi, M. caprae, M. orygis, M. mungi |
2 working days |
| Viral Meningitis Panel
|
Adenovirus, CMV, EBV, HSV 1 & 2, VZV, enterovirus, parechovirus, herpesviruses 6 & 7, parvovirus B19 | 2 working days |
| Bacterial Meningitis Panel | Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, Streptococcus agalactiae (Group B), Escherichia coli and Listeria monocytogenes | Up to 2 working days |
| H1N1 & Flu Panel
|
Flu A, Flu B, pandemic H1N1 and seasonal H1N1 | 2 working days |
| Respiratory Pathogens Panel (viral and bacterial pathogens ) | Flu A, Flu B, Flu C, Klebsiella pneumoniae, Mycoplasma pneumoniae, Parainfluenza 1, Parainfluenza 2, Parainfluenza 3, Parainfluenza 4, Enterovirus, Metapneumovirus, RSV A/B, Bocavirus, Rhinovirus, Pandemic H1N1, Seasonal H1N1, Salmonella enterica, Adenovirus, Moraxella catarrhalis, Bordetela pertussis, Haemophilus influenzae type B, Parechovirus, Staphylococcus aureus, Pneumocystis jirovecii, Streptococcus pneumoniae, Legionella pneumophila, Coronavirus 229E, Coronavirus OC43, Coronavirus NL63, Coronavirus HKU 1, Chlamydia pneumoniae and Legionella pneumophila /longbeachae | 2 working days |
| Sexually Transmitted Diseases Panel
|
Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhea, Trichomonas vaginalis, Gardnerella vaginalis, Treponema pallidum, HSV 1&2 | 4 working days |
| HPV High Risk Screening Panel
|
HPV (16 & 18), HPV (33, 35, 39, 45, 52, 58 and 66), HPV (31, 51, 56, 59 and 68) | 4 working days |
| Vibrio Cholera | Vibrio cholera O1, O139 and Cholera enterotoxin gene | Up to 2 working days |
| Gastroenteritis Panel | Astrovirus, Rotavirus, Norovirus Genotype I, Norovirus Genotype II, Adenovirus, Clostridium difficile, Campylobacter spp., Salmonella spp., enteroinvasive E. coli (EIEC) and Shigella spp., verotoxigenic E. coli (VTEC), Yersinia enterocolitica, Entamoeba histolytica, Cryptosporidium spp., and Giardia duodenalis | Up to 2 working days |
| Blood Viral Panel | adenovirus, CMV, EBV, HSV 1 & 2, VZV, enterovirus, parechovirus, herpesviruses 6 & 7, parvovirus B19 | Up to 2 working days |
Molecular Oncology and Genetics:
| Targets | Results available within | |
| Thrombophilia (FV, FII, MTHFR) | Factor II Prothrombin, Factor V Leiden, MTHFR 677 and 1298 | 4 working days |
| Familial Mediterranean Fever Panel (20 mutations) | 20 mutations in MEFV gene: In exon 1; E84K, in exon 2; L110P, E148Q, E148V, E167D, E230K/Q, T267I, P283L, G304R, in exon 3; P369S, in exon 5; F479L and in exon 10; M680I (G/C-A), M694I, M694V, K695R, V726A, A744S, R761H | 4 working days |
| BCR-ABL – Quantitative | b2a2 and b3a2 fusion mRNA transcripts resulting from two major breakpoints and encoding the p210 isoform of BCR-ABL1 | 3 working days |
| JAK-2 (V617F) | JAK-2 V617F mutation (in exon 14) | 4 working days |
| HLA B27 |
HLA B27 allele subtypes | 4 working days |
| MPN Panel (JAK-2 / MPL / CALR / CSF3R)
|
Most prevalent JAK-2 gene Exon 12 mutations, JAK-2 Exon 14 gene V617F mutation, MPL gene Exon 10; S505N, W515A, W515K, W515L, W515R mutations, CALR gene Exon 9; Type 1, Type 2 and other mutations and CSF3R gene; T615A and T618I mutations. | 4 working days |
*SARS-CoV-2 PCR:
COVID PCR is available at Bellevue Medical Center through walk-in (B1 level, next to ER entrance). For your convenience, a QR code is provided with your PCR results.
Authorized by the Ministry of Public Health.
PCR walk-in opening hours: Monday to Friday: 8 a.m. to 4 p.m.
Please make sure to bring with you your ID card or passport for travel purposes and the exact amount of 8$ to be paid in cash.
For more information, please contact the hotline: 01-698398
